Indication
Refractory Systemic Lupus Erythematosus
1 clinical trial
1 product
1 drug
Clinical trial
Remission Induction Therapy for Refractory Systemic Lupus Erythematosus With Autologous Hematopoietic Stem Cell Transplantation (AHSCT) Versus Rituximab (antiCD20) Followed by Maintenance Therapy With Mycophenolate Mofetil (MMF)Status: Withdrawn, Estimated PCD: 2013-07-01
Drug
Varlilumab